Patent · US Active

Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment

US11324777B2 · kind B2 · utility

0Cited by
15References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 29, 2017
Grant dateMay 10, 2022
Priority date
Expiry dateJan 17, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2502/1121
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of generating an isolated population of cells comprising anti-third party cells having a central memory T-lymphocyte (Tcm) phenotype, the cells being tolerance-inducing cells and/or endowed with anti-disease activity, and capable of homing to the lymph nodes following transplantation is disclosed. The method comprising: (a) contacting peripheral blood mononuclear cells (PBMC) with a third party antigen or antigens in the presence of IL-21 so as to allow enrichment of antigen reactive cells; and (b) culturing the cells resulting from step (a) in the presence of IL-21, IL-15 and IL-7 in an antigen free environment so as to allow proliferation of cells comprising the central memory T-lymphocyte (Tcm) phenotype.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.